$177 Million is the total value of Iguana Healthcare Management, LLC's 62 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TNDM | Exit | TANDEM DIABETES CARE INC | $0 | – | -100,000 | -100.0% | -0.06% | – |
| Exit | ONCOMED PHARMACEUTICALS INCcall | $0 | – | -50,000 | -100.0% | -0.23% | – | |
| AGTC | Exit | APPLIED GENETIC TECHNOL CORP | $0 | – | -75,000 | -100.0% | -0.26% | – |
| AUPH | Exit | AURINIA PHARMACEUTICALS INC | $0 | – | -75,000 | -100.0% | -0.27% | – |
| NERV | Exit | MINERVA NEUROSCIENCES INC | $0 | – | -100,000 | -100.0% | -0.40% | – |
| TBPH | Exit | THERAVANCE BIOPHARMA INC | $0 | – | -25,000 | -100.0% | -0.46% | – |
| Exit | MYLAN N Vcall | $0 | – | -25,000 | -100.0% | -0.48% | – | |
| ZYNE | Exit | ZYNERBA PHARMACEUTICALS INC | $0 | – | -50,000 | -100.0% | -0.50% | – |
| RARX | Exit | RA PHARMACEUTICALS INC | $0 | – | -50,000 | -100.0% | -0.53% | – |
| ELGX | Exit | ENDOLOGIX INC | $0 | – | -150,000 | -100.0% | -0.54% | – |
| PACB | Exit | PACIFIC BIOSCIENCES CALIF IN | $0 | – | -215,000 | -100.0% | -0.55% | – |
| Exit | MEDICINES COcall | $0 | – | -25,000 | -100.0% | -0.60% | – | |
| IPXL | Exit | IMPAX LABORATORIES INC | $0 | – | -100,000 | -100.0% | -0.63% | – |
| Exit | BRISTOL MYERS SQUIBB COcall | $0 | – | -25,000 | -100.0% | -0.67% | – | |
| Exit | BIOVERATIV INCcall | $0 | – | -25,000 | -100.0% | -0.67% | – | |
| AZN | Exit | ASTRAZENECA PLCsponsored adr | $0 | – | -50,000 | -100.0% | -0.77% | – |
| ALDR | Exit | ALDER BIOPHARMACEUTICALS INC | $0 | – | -75,000 | -100.0% | -0.77% | – |
| GILD | Exit | GILEAD SCIENCES INC | $0 | – | -25,000 | -100.0% | -0.84% | – |
| MZOR | Exit | MAZOR ROBOTICS LTDsponsored ads | $0 | – | -58,000 | -100.0% | -0.85% | – |
| PCRX | Exit | PACIRA PHARMACEUTICALS INC | $0 | – | -40,000 | -100.0% | -0.90% | – |
| LHCG | Exit | LHC GROUP INC | $0 | – | -35,000 | -100.0% | -0.93% | – |
| MDRX | Exit | ALLSCRIPTS HEALTHCARE SOLUTN | $0 | – | -150,000 | -100.0% | -0.94% | – |
| Exit | WALGREENS BOOTS ALLIANCE INCcall | $0 | – | -25,000 | -100.0% | -1.03% | – | |
| TVTY | Exit | TIVITY HEALTH INC | $0 | – | -75,000 | -100.0% | -1.08% | – |
| ACRS | Exit | ACLARIS THERAPEUTICS INC | $0 | – | -75,000 | -100.0% | -1.11% | – |
| CAH | Exit | CARDINAL HEALTH INC | $0 | – | -30,000 | -100.0% | -1.21% | – |
| SUPN | Exit | SUPERNUS PHARMACEUTICALS INC | $0 | – | -90,000 | -100.0% | -1.39% | – |
| WBA | Exit | WALGREENS BOOTS ALLIANCE INC | $0 | – | -35,000 | -100.0% | -1.44% | – |
| AMGN | Exit | AMGEN INC | $0 | – | -50,000 | -100.0% | -4.06% | – |
| Exit | SPDR S&P 500 ETF TRput | $0 | – | -50,000 | -100.0% | -5.83% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOGEN INC | 17 | Q1 2018 | 7.5% |
| ULTRAGENYX PHARMACEUTICAL IN | 17 | Q1 2018 | 6.7% |
| MERCK & CO INC NEW | 16 | Q1 2018 | 5.4% |
| CELGENE CORP | 15 | Q4 2017 | 7.9% |
| AERIE PHARMACEUTICALS INC | 15 | Q4 2017 | 3.3% |
| GILEAD SCIENCES INC | 14 | Q1 2017 | 6.7% |
| ESPERION THERAPEUTICS INC NE | 14 | Q1 2018 | 7.8% |
| SUPERNUS PHARMACEUTICALS INC | 14 | Q4 2017 | 2.8% |
| DERMIRA INC | 14 | Q1 2018 | 2.7% |
| AMGEN INC | 13 | Q1 2017 | 6.5% |
View Iguana Healthcare Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2018-05-15 |
| 13F-HR | 2018-02-14 |
| 13F-HR/A | 2017-11-16 |
| 13F-HR | 2017-11-14 |
| 13F-HR | 2017-08-14 |
| 13F-HR | 2017-05-15 |
| 13F-HR | 2017-02-14 |
| 13F-HR/A | 2016-11-17 |
| 13F-HR | 2016-11-14 |
| 13F-HR/A | 2016-11-04 |
View Iguana Healthcare Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.